# Tolerance and Effect on Intraocular Pressure After Administration of SYL040012

> **NCT00990743** · PHASE1 · COMPLETED · sponsor: **Sylentis, S.A.** · enrollment: 30 (actual)

## Conditions studied

- Ocular Hypertension
- Glaucoma

## Interventions

- **DRUG:** SYL040012

## Key facts

- **NCT ID:** NCT00990743
- **Lead sponsor:** Sylentis, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2010-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00990743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00990743, "Tolerance and Effect on Intraocular Pressure After Administration of SYL040012". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00990743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*